Öne Çıkan Yayınları
EDA2R-NIK signalling promotes muscle atrophy linked to cancer cachexia. Bilgic SN, Domaniku A, Toledo B, Agca S, Weber BZC, Arabaci DH, Ozornek Z, Lause P, Thissen JP, Loumaye A, Kir S. Nature (2023) 617: 827-834.
Inhibition of epidermal growth factor receptor suppresses parathyroid hormone-related protein expression in tumours and ameliorates cancer-associated cachexia. Weber BZC, Agca S, Domaniku A, Bilgic SN, Arabaci DH, Kir S. J Cachexia Sarcopenia Muscle (2022) 13(3):1582-1594.
PTH/PTHrP receptor mediates cachexia in models of kidney failure and cancer. Kir S, Komaba H, Garcia AP, Konstantinos E, Suh H, Lanske B, Hodin RA, Spiegelman BM. Cell Metab (2016) 23: 315-323.
Tumour-derived PTH-related protein triggers adipose tissue browning and cancer cachexia. Kir S, White JP, Kleiner S, Kazak L, Cohen P, Baracos VE, Spiegelman BM. Nature (2014) 513: 100-104.
FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis. Kir S, Beddow SA, Samuel VT, Miller P, Previs SF, Suino-Powell K, Xu HE, Shulman GI, Kliewer SA, Mangelsdorf DJ. Science (2011) 331: 1621-24.